LANTUS insulin glargine The first and only peakless insulin analog, created in 2000 (Germany), from 2757 sister brands and 17478 competing brands. The LANTUS insulin glargine The first and only peakless insulin analog brand is owned by SANOFI, a company listed in Paris. The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. LANTUS insulin glargine The first and only peakless insulin analog belongs to the Drug Manufacturers business sector.

LANTUS insulin glargine The first and only peakless insulin analog is a brand of SANOFI (SAN) Sustainability

Here is the evolution of interest in SANOFI "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability: Result of Google's query: "LANTUS insulin glargine The first and only peakless insulin analog sustainability"
: Sustainability -> Share price